Stepan Company

NYSE:SCL

Chemicals - Specialty

Basic Materials
$66.05 +0.85%

+$0.46 today

Market cap
$1.50B
Beta
0.97
P/E (TTM)
-87.3
EPS (TTM)
-$0.62
Dividend yield
2.89%
52W Low $41.82High $68.00

Volume 0.13M

Average 0.15M

SCL Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Stepan CompanyNYSE: SCL

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development grows, but more slowly than its trailing trend

Q1 FY2026 research & development of $14.99M rose 2.3% year over year, behind the +6.3% change in trailing-twelve-month research & development. Sequentially, it fell 4.5% from the prior quarter. Over 3 fiscal years it compounded at -3.8% a year.

Context

  • Research & development amounted to 2.5% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +2.3% toward the trailing-twelve-month pace of +6.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$14.99M-4.5% QoQ
Last fiscal yearDec 2025
$59.28M+6.5% YoY
LTMMar 2026
$59.62M+6.3% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.3%——
1 year+6.5%——
3-year CAGR-3.8%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
59.28M USD
Year-over-year change
+6.5%
4-year CAGR
-1.4%

Research & Development vs competitors

How SCL compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +6.3% is the 2nd highest of 4, against a peer median of -9.9%.
  • Research & development amounts to 2.5% of revenue for SCL, versus a peer median of 0.0%.
SCL Competitors
Research & Development for SCL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BAKBraskem S.A.LTM Mar 2026R$436M BRL-9.9%+6.4%0.7%
SCLStepan CompanyLTM Mar 2026$59.62M USD+6.3%-3.8%2.5%
ASPIASP Isotopes Inc. Common StockLTM Mar 2026$16.09M USD+261.3%+113.3%59.8%
REXREX American Resources CorporationLTM Apr 2026$0 USD——0.0%
ECVTEcovyst Inc.LTM Mar 2026$0 USD——0.0%
UANCVR Partners, LPLTM Mar 2026$0 USD——0.0%
ODCOil-Dri Corporation of AmericaLTM Apr 2026$0 USD—+4.5%0.0%
GPREGreen Plains Inc.LTM Mar 2026$0 USD-100.0%—0.0%
MUXMcEwen Mining Inc.LTM Mar 2026$0 USD——0.0%
KOPKoppers Holdings Inc.LTM Mar 2026$0 USD——0.0%
GSMFerroglobe PLCLTM Mar 2026$0 USD——0.0%
Peer median (excluding SCL) —-9.9%+6.4%0.0%

Competitors are the stored peer set for SCL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.35B2.77B2.33B2.18B2.33B
Cost of Revenue1.95B2.35B2.05B1.91B2.06B
Gross Profit395.81M427.07M277.6M272.21M269.89M
Gross Margin16.9%15.4%11.9%12.5%11.6%
Research & Development62.69M66.63M59.04M55.67M59.28M
Selling, General & Admin152.09M161.21M141.57M143.91M139.56M
Operating Expenses225.03M219.73M218.99M201.73M200.51M
Depreciation & Amortization90.88M94.65M105.34M112.2M126.04M
EBITDA270.42M294.24M169.68M192.1M212.17M
EBITDA Margin11.5%10.6%7.3%8.8%9.1%
Operating Income170.78M207.34M58.61M70.48M69.38M
Operating Margin7.3%7.5%2.5%3.2%3.0%
Interest Income1.26M1.08M3.84M5.28M4.11M
Interest Expense7.01M10.89M15.95M19.47M26.23M
Other Income / Expenses1.76M(18.63M)(10.22M)(10.04M)(9.48M)
Income Before Tax172.54M188.7M48.39M60.44M59.9M
Pre-Tax Margin7.4%6.8%2.1%2.8%2.6%
Income Tax Expense34.64M41.55M8.19M10.07M13.01M
Net Income137.8M147.15M40.2M50.37M46.9M
Net Margin5.9%5.3%1.7%2.3%2.0%
EPS (Basic)6.016.461.772.212.05
EPS (Diluted)5.926.381.752.202.05
Weighted Avg Shares22.92M22.78M22.78M22.9M22.87M
Weighted Avg Shares (Diluted)23.29M23.06M22.95M22.93M22.89M

Stepan Company

NYSE:SCL

Intrinsic Alpha fair value

Locked

Current Price

$66.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.